+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Dermatophytic Onychomycosis Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)- Product Image
Dermatophytic Onychomycosis Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)- Product Image
New

Dermatophytic Onychomycosis Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 300 Pages
  • September 2025
  • Region: Global
  • Fairfield Market Research
  • ID: 5934306
Description Jump to:
The global dermatophytic onychomycosis therapeutics market size is likely to be valued at US$ 6.95 Bn in 2025 and is estimated to reach US$ 11 Bn by 2032, growing at a CAGR of 6.78% during the forecast period 2025-2032. Growing awareness of fungal nail infections, coupled with the rising prevalence of chronic conditions like diabetes and weakened immunity, is expected to propel demand for effective treatment options. Increased investments in advanced antifungal therapies and novel delivery methods are also shaping the future of this market.

Market Insights

The dermatophytic onychomycosis therapeutics market encompasses a diverse range of treatment modalities aimed at addressing fungal nail infections caused by dermatophytes. These infections are among the most common nail disorders worldwide and often require long-term therapeutic intervention. Current treatment approaches include topical antifungals, oral antifungals, laser therapy, and combination therapies, each tailored to different severity levels of the condition. The market growth is supported by technological advancements in drug formulations, an expanding elderly population more prone to nail disorders, and greater awareness among patients seeking timely treatment.

Market Growth Drivers

The market is witnessing strong growth driven by multiple factors. Rising global prevalence of onychomycosis, particularly among aging populations, has significantly increased demand for effective therapeutics. Advancements in antifungal drug development and combination therapies have improved efficacy and reduced recurrence rates, boosting adoption. Growing healthcare expenditure and awareness programs encouraging early diagnosis of fungal infections are further propelling market expansion. Additionally, the emergence of laser and photodynamic therapies as minimally invasive solutions has broadened treatment options and attracted wider patient acceptance.

Market Restraints

Despite promising growth, several restraints hinder market performance. Long treatment durations and high recurrence rates of onychomycosis often discourage patient adherence, limiting therapy outcomes. Adverse side effects associated with oral antifungals, such as liver toxicity and drug interactions, also act as barriers to widespread use. The high cost of advanced therapies like laser treatment further restricts accessibility in developing economies. Moreover, limited awareness in rural regions and the availability of over-the-counter remedies, which are less effective, continue to challenge the adoption of prescription therapeutics.

Market Opportunities

Emerging opportunities lie in the development of innovative antifungal formulations with improved bioavailability and faster treatment cycles. The increasing adoption of e-commerce and online pharmacies is creating new distribution channels for antifungal drugs, expanding access to a larger consumer base. Rising investment in research and development for laser and photodynamic therapies is likely to boost advanced treatment adoption. Additionally, expanding healthcare infrastructure in Asia-Pacific and Latin America, coupled with strategic collaborations between pharmaceutical companies and dermatology clinics, offers significant room for market growth in the forecast period.

Regional Outlook

The global dermatophytic onychomycosis therapeutics market exhibits strong regional variations. North America remains a dominant region due to high disease prevalence, advanced healthcare infrastructure, and the availability of innovative antifungal therapies. Europe follows closely, supported by increased awareness, favorable reimbursement policies, and strong presence of pharmaceutical companies. Asia-Pacific is projected to witness the fastest growth, driven by large patient populations, rising healthcare expenditure, and improving access to dermatological treatments. Meanwhile, Latin America and the Middle East & Africa present untapped opportunities, where growing healthcare investments and awareness campaigns are likely to fuel demand over the coming years.

Leading Companies

Leading companies in the global dermatophytic onychomycosis therapeutics market are actively investing in product innovation, strategic partnerships, and expanding distribution networks to strengthen their market presence. These players are focusing on developing advanced drug formulations, minimally invasive therapies, and combination treatments to enhance patient outcomes and reduce recurrence rates.

Companies Covered in This Report:

  • Bausch Health
  • Galderma S.A.
  • Novartis AG
  • Pfizer, Inc.
  • Moberg Pharma AB
  • Bayer AG
  • Dr. Reddy’s Laboratories Ltd.
  • Cipla Ltd.
  • Medimetriks Pharmaceuticals, Inc.
  • Sanofi S.A.
  • GlaxoSmithKline Plc.
  • Teva Pharmaceutical Industries Ltd.
  • Cardinal Health Inc.
  • Viatris Inc.
  • Almirall, S.A.
  • Vanda Pharmaceuticals Inc.
  • Others

Market Segmentation

By Treatment Type

  • Drug-Based Treatment
  • Topical Antifungals
  • Oral Antifungals
  • Laser Therapy
  • Photodynamic Therapy
  • Combination Therapy

By Indication

  • Distal Subungual Onychomycosis
  • White Superficial Onychomycosis
  • Proximal Subungual Onychomycosis
  • Candidal Onychomycosis
  • Total Dystrophic Onychomycosis

By End-user

  • Institutional Sales
  • Hospitals
  • Dermatology Clinics
  • Retail Sales
  • Retail Pharmacies
  • Drug Stores
  • Mail Order Pharmacies & Online Sales

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Dermatophytic Onychomycosis Therapeutics Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2024
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Dermatophytic Onychomycosis Therapeutics Market Outlook, 2019-2032
3.1. Global Dermatophytic Onychomycosis Therapeutics Market Outlook, by Treatment, Value (US$ Bn), 2019-2032
3.1.1. Key Highlights
3.1.1.1. Dermatophytic Onychomycosis Therapeutic Drugs
3.1.1.1.1. Oral
3.1.1.1.1.1. Rx
3.1.1.1.1.2. OTC
3.1.1.1.2. Topical
3.1.1.1.2.1. Rx
3.1.1.1.2.2. OTC
3.1.1.2. Dermatophytic Onychomycosis Therapeutic Lasers
3.1.1.2.1. C02 Ablative Lasers
3.1.1.2.2. Nd:YAG Lasers
3.1.1.2.3. Dual-wavelength near-infrared Lasers
3.1.1.3. Photodynamic Therapy
3.2. Global Dermatophytic Onychomycosis Therapeutics Market Outlook, by Indication, Value (US$ Bn), 2019-2032
3.2.1. Key Highlights
3.2.1.1. Distal Subungual Onychomycosis
3.2.1.2. White Superficial Onychomycosis
3.2.1.3. Proximal Subungual Onychomycosis
3.2.1.4. Candidal Onychomycosis
3.2.1.5. Total Dystrophic Onychomycosis
3.3. Global Dermatophytic Onychomycosis Therapeutics Market Outlook, by Gender, Value (US$ Bn), 2019-2032
3.3.1. Key Highlights
3.3.1.1. Male
3.3.1.2. Female
3.4. Global Dermatophytic Onychomycosis Therapeutics Market Outlook, by Age Group, Value (US$ Bn), 2019-2032
3.4.1. Key Highlights
3.4.1.1. 0-18 Years
3.4.1.2. 18-39 Years
3.4.1.3. 40-64 Years
3.4.1.4. 65 Years and Above
3.5. Global Dermatophytic Onychomycosis Therapeutics Market Outlook, by Distribution Channel, Value (US$ Bn), 2019-2032
3.5.1. Key Highlights
3.5.1.1. Institutional Sales
3.5.1.1.1. Hospitals
3.5.1.1.2. Dermatology Clinics
3.5.1.2. Retail Sales
3.5.1.2.1. Retail Pharmacies
3.5.1.2.2. Drug Stores
3.5.1.2.3. Mail Order Pharmacies & Online Sales
3.6. Global Dermatophytic Onychomycosis Therapeutics Market Outlook, by Region, Value (US$ Bn), 2019-2032
3.6.1. Key Highlights
3.6.1.1. North America
3.6.1.2. Europe
3.6.1.3. Asia Pacific
3.6.1.4. Latin America
3.6.1.5. Middle East & Africa
4. North America Dermatophytic Onychomycosis Therapeutics Market Outlook, 2019-2032
4.1. North America Dermatophytic Onychomycosis Therapeutics Market Outlook, by Treatment, Value (US$ Bn), 2019-2032
4.1.1. Key Highlights
4.1.1.1. Dermatophytic Onychomycosis Therapeutic Drugs
4.1.1.1.1. Oral
4.1.1.1.1.1. Rx
4.1.1.1.1.2. OTC
4.1.1.1.2. Topical
4.1.1.1.2.1. Rx
4.1.1.1.2.2. OTC
4.1.1.2. Dermatophytic Onychomycosis Therapeutic Lasers
4.1.1.2.1. C02 Ablative Lasers
4.1.1.2.2. Nd:YAG Lasers
4.1.1.3. Dual-wavelength near-infrared Lasers
4.2. North America Dermatophytic Onychomycosis Therapeutics Market Outlook, by Indication, Value (US$ Bn), 2019-2032
4.2.1. Key Highlights
4.2.1.1. Distal Subungual Onychomycosis
4.2.1.2. White Superficial Onychomycosis
4.2.1.3. Proximal Subungual Onychomycosis
4.2.1.4. Candidal Onychomycosis
4.2.1.5. Total Dystrophic Onychomycosis
4.3. North America Dermatophytic Onychomycosis Therapeutics Market Outlook, by Gender, Value (US$ Bn), 2019-2032
4.3.1. Key Highlights
4.3.1.1. Male
4.3.1.2. Female
4.4. North America Dermatophytic Onychomycosis Therapeutics Market Outlook, by Age Group, Value (US$ Bn), 2019-2032
4.4.1. Key Highlights
4.4.1.1. 0-18 Years
4.4.1.2. 18-39 Years
4.4.1.3. 40-64 Years
4.4.1.4. 65 Years and Above
4.5. North America Dermatophytic Onychomycosis Therapeutics Market Outlook, by Distribution Channel, Value (US$ Bn), 2019-2032
4.5.1. Key Highlights
4.5.1.1. Institutional Sales
4.5.1.1.1. Hospitals
4.5.1.1.2. Dermatology Clinics
4.5.1.2. Retail Sales
4.5.1.2.1. Retail Pharmacies
4.5.1.2.2. Drug Stores
4.5.1.2.3. Mail Order Pharmacies & Online Sales
4.5.2. BPS Analysis/Market Attractiveness Analysis
4.6. North America Dermatophytic Onychomycosis Therapeutics Market Outlook, by Country, Value (US$ Bn), 2019-2032
4.6.1. Key Highlights
4.6.1.1. U.S. Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2019-2032
4.6.1.2. U.S. Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2019-2032
4.6.1.3. U.S. Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2019-2032
4.6.1.4. U.S. Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2019-2032
4.6.1.5. U.S. Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019-2032
4.6.1.6. Canada Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2019-2032
4.6.1.7. Canada Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2019-2032
4.6.1.8. Canada Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2019-2032
4.6.1.9. Canada Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2019-2032
4.6.1.10. Canada Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019-2032
4.6.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Dermatophytic Onychomycosis Therapeutics Market Outlook, 2019-2032
5.1. Europe Dermatophytic Onychomycosis Therapeutics Market Outlook, by Treatment, Value (US$ Bn), 2019-2032
5.1.1. Key Highlights
5.1.1.1. Dermatophytic Onychomycosis Therapeutic Drugs
5.1.1.1.1. Oral
5.1.1.1.1.1. Rx
5.1.1.1.1.2. OTC
5.1.1.1.2. Topical
5.1.1.1.2.1. Rx
5.1.1.1.2.2. OTC
5.1.1.2. Dermatophytic Onychomycosis Therapeutic Lasers
5.1.1.2.1. C02 Ablative Lasers
5.1.1.2.2. Nd:YAG Lasers
5.1.1.3. Dual-wavelength near-infrared Lasers
5.2. Europe Dermatophytic Onychomycosis Therapeutics Market Outlook, by Indication, Value (US$ Bn), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Distal Subungual Onychomycosis
5.2.1.2. White Superficial Onychomycosis
5.2.1.3. Proximal Subungual Onychomycosis
5.2.1.4. Candidal Onychomycosis
5.2.1.5. Total Dystrophic Onychomycosis
5.3. Europe Dermatophytic Onychomycosis Therapeutics Market Outlook, by Gender, Value (US$ Bn), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Male
5.3.1.2. Female
5.4. Europe Dermatophytic Onychomycosis Therapeutics Market Outlook, by Age Group, Value (US$ Bn), 2019-2032
5.4.1. Key Highlights
5.4.1.1. 0-18 Years
5.4.1.2. 18-39 Years
5.4.1.3. 40-64 Years
5.4.1.4. 65 Years and Above
5.5. Europe Dermatophytic Onychomycosis Therapeutics Market Outlook, by Distribution Channel, Value (US$ Bn), 2019-2032
5.5.1. Key Highlights
5.5.1.1. Institutional Sales
5.5.1.1.1. Hospitals
5.5.1.1.2. Dermatology Clinics
5.5.1.2. Retail Sales
5.5.1.2.1. Retail Pharmacies
5.5.1.2.2. Drug Stores
5.5.1.2.3. Mail Order Pharmacies & Online Sales
5.5.2. BPS Analysis/Market Attractiveness Analysis
5.6. Europe Dermatophytic Onychomycosis Therapeutics Market Outlook, by Country, Value (US$ Bn), 2019-2032
5.6.1. Key Highlights
5.6.1.1. Germany Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2019-2032
5.6.1.2. Germany Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2019-2032
5.6.1.3. Germany Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2019-2032
5.6.1.4. Germany Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2019-2032
5.6.1.5. Germany Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019-2032
5.6.1.6. U.K. Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2019-2032
5.6.1.7. U.K. Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2019-2032
5.6.1.8. U.K. Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2019-2032
5.6.1.9. U.K. Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2019-2032
5.6.1.10. U.K. Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019-2032
5.6.1.11. France Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2019-2032
5.6.1.12. France Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2019-2032
5.6.1.13. France Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2019-2032
5.6.1.14. France Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2019-2032
5.6.1.15. France Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019-2032
5.6.1.16. Italy Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2019-2032
5.6.1.17. Italy Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2019-2032
5.6.1.18. Italy Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2019-2032
5.6.1.19. Italy Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2019-2032
5.6.1.20. Italy Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019-2032
5.6.1.21. Turkey Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2019-2032
5.6.1.22. Turkey Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2019-2032
5.6.1.23. Turkey Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2019-2032
5.6.1.24. Turkey Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2019-2032
5.6.1.25. Turkey Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019-2032
5.6.1.26. Russia Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2019-2032
5.6.1.27. Russia Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2019-2032
5.6.1.28. Russia Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2019-2032
5.6.1.29. Russia Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2019-2032
5.6.1.30. Russia Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019-2032
5.6.1.31. Rest of Europe Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2019-2032
5.6.1.32. Rest of Europe Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2019-2032
5.6.1.33. Rest of Europe Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2019-2032
5.6.1.34. Rest of Europe Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2019-2032
5.6.1.35. Rest of Europe Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019-2032
5.6.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Outlook, 2019-2032
6.1. Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Outlook, by Treatment, Value (US$ Bn), 2019-2032
6.1.1.1. Key Dermatophytic Onychomycosis Therapeutic Drugs
6.1.1.1.1. Oral
6.1.1.1.1.1. Rx
6.1.1.1.1.2. OTC
6.1.1.1.2. Topical
6.1.1.1.2.1. Rx
6.1.1.1.2.2. OTC
6.1.1.2. Dermatophytic Onychomycosis Therapeutic Lasers
6.1.1.2.1. C02 Ablative Lasers
6.1.1.2.2. Nd:YAG Lasers
6.1.2. Dual-wavelength near-infrared Lasers
6.2. Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Outlook, by Indication, Value (US$ Bn), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Distal Subungual Onychomycosis
6.2.1.2. White Superficial Onychomycosis
6.2.1.3. Proximal Subungual Onychomycosis
6.2.1.4. Candidal Onychomycosis
6.2.1.5. Total Dystrophic Onychomycosis
6.3. Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Outlook, by Gender, Value (US$ Bn), 2019-2032
6.3.1. Key Highlights
6.3.1.1. Male
6.3.1.2. Female
6.4. Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Outlook, by Age Group, Value (US$ Bn), 2019-2032
6.4.1. Key Highlights
6.4.1.1. 0-18 Years
6.4.1.2. 18-39 Years
6.4.1.3. 40-64 Years
6.4.1.4. 65 Years and Above
6.5. Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Outlook, by Distribution Channel, Value (US$ Bn), 2019-2032
6.5.1. Key Highlights
6.5.1.1. Institutional Sales
6.5.1.1.1. Hospitals
6.5.1.1.2. Dermatology Clinics
6.5.1.2. Retail Sales
6.5.1.2.1. Retail Pharmacies
6.5.1.2.2. Drug Stores
6.5.1.2.3. Mail Order Pharmacies & Online Sales
6.5.2. BPS Analysis/Market Attractiveness Analysis
6.6. Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Outlook, by Country, Value (US$ Bn), 2019-2032
6.6.1. Key Highlights
6.6.1.1. China Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2019-2032
6.6.1.2. China Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2019-2032
6.6.1.3. China Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2019-2032
6.6.1.4. China Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2019-2032
6.6.1.5. China Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019-2032
6.6.1.6. Japan Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2019-2032
6.6.1.7. Japan Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2019-2032
6.6.1.8. Japan Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2019-2032
6.6.1.9. Japan Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2019-2032
6.6.1.10. Japan Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019-2032
6.6.1.11. South Korea Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2019-2032
6.6.1.12. South Korea Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2019-2032
6.6.1.13. South Korea Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2019-2032
6.6.1.14. South Korea Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2019-2032
6.6.1.15. South Korea Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019-2032
6.6.1.16. India Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2019-2032
6.6.1.17. India Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2019-2032
6.6.1.18. India Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2019-2032
6.6.1.19. India Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2019-2032
6.6.1.20. India Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019-2032
6.6.1.21. Southeast Asia Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2019-2032
6.6.1.22. Southeast Asia Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2019-2032
6.6.1.23. Southeast Asia Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2019-2032
6.6.1.24. Southeast Asia Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2019-2032
6.6.1.25. Southeast Asia Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019-2032
6.6.1.26. Rest of Asia Pacific Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2019-2032
6.6.1.27. Rest of Asia Pacific Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2019-2032
6.6.1.28. Rest of Asia Pacific Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2019-2032
6.6.1.29. Rest of Asia Pacific Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2019-2032
6.6.1.30. Rest of Asia Pacific Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019-2032
6.6.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Dermatophytic Onychomycosis Therapeutics Market Outlook, 2019-2032
7.1. Latin America Dermatophytic Onychomycosis Therapeutics Market Outlook, by Treatment, Value (US$ Bn), 2019-2032
7.1.1. Key Highlights
7.1.1.1. Dermatophytic Onychomycosis Therapeutic Drugs
7.1.1.1.1. Oral
7.1.1.1.1.1. Rx
7.1.1.1.1.2. OTC
7.1.1.1.2. Topical
7.1.1.1.2.1. Rx
7.1.1.1.2.2. OTC
7.1.1.2. Dermatophytic Onychomycosis Therapeutic Lasers
7.1.1.2.1. C02 Ablative Lasers
7.1.1.2.2. Nd:YAG Lasers
7.1.1.3. Dual-wavelength near-infrared Lasers
7.2. Latin America Dermatophytic Onychomycosis Therapeutics Market Outlook, by Indication, Value (US$ Bn), 2019-2032
7.2.1.1. Distal Subungual Onychomycosis
7.2.1.2. White Superficial Onychomycosis
7.2.1.3. Proximal Subungual Onychomycosis
7.2.1.4. Candidal Onychomycosis
7.2.1.5. Total Dystrophic Onychomycosis
7.3. Latin America Dermatophytic Onychomycosis Therapeutics Market Outlook, by Gender, Value (US$ Bn), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Male
7.3.1.2. Female
7.4. Latin America Dermatophytic Onychomycosis Therapeutics Market Outlook, by Age Group, Value (US$ Bn), 2019-2032
7.4.1. Key Highlights
7.4.1.1. 0-18 Years
7.4.1.2. 18-39 Years
7.4.1.3. 40-64 Years
7.4.1.4. 65 Years and Above
7.5. Latin America Dermatophytic Onychomycosis Therapeutics Market Outlook, by Distribution Channel, Value (US$ Bn), 2019-2032
7.5.1. Key Highlights
7.5.1.1. Institutional Sales
7.5.1.1.1. Hospitals
7.5.1.1.2. Dermatology Clinics
7.5.1.2. Retail Sales
7.5.1.2.1. Retail Pharmacies
7.5.1.2.2. Drug Stores
7.5.1.2.3. Mail Order Pharmacies & Online Sales
7.5.2. BPS Analysis/Market Attractiveness Analysis
7.6. Latin America Dermatophytic Onychomycosis Therapeutics Market Outlook, by Country, Value (US$ Bn), 2019-2032
7.6.1. Key Highlights
7.6.1.1. Brazil Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2019-2032
7.6.1.2. Brazil Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2019-2032
7.6.1.3. Brazil Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2019-2032
7.6.1.4. Brazil Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2019-2032
7.6.1.5. Brazil Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019-2032
7.6.1.6. Mexico Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2019-2032
7.6.1.7. Mexico Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2019-2032
7.6.1.8. Mexico Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2019-2032
7.6.1.9. Mexico Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2019-2032
7.6.1.10. Mexico Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019-2032
7.6.1.11. Argentina Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2019-2032
7.6.1.12. Argentina Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2019-2032
7.6.1.13. Argentina Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2019-2032
7.6.1.14. Argentina Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2019-2032
7.6.1.15. Argentina Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019-2032
7.6.1.16. Rest of Latin America Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2019-2032
7.6.1.17. Rest of Latin America Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2019-2032
7.6.1.18. Rest of Latin America Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2019-2032
7.6.1.19. Rest of Latin America Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2019-2032
7.6.1.20. Rest of Latin America Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019-2032
7.6.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Dermatophytic Onychomycosis Therapeutics Market Outlook, 2019-2032
8.1. Middle East & Africa Dermatophytic Onychomycosis Therapeutics Market Outlook, by Treatment, Value (US$ Bn), 2019-2032
8.1.1. Key Highlights
8.1.1.1. Dermatophytic Onychomycosis Therapeutic Drugs
8.1.1.1.1. Oral
8.1.1.1.1.1. Rx
8.1.1.1.1.2. OTC
8.1.1.1.2. Topical
8.1.1.1.2.1. Rx
8.1.1.1.2.2. OTC
8.1.1.2. Dermatophytic Onychomycosis Therapeutic Lasers
8.1.1.2.1. C02 Ablative Lasers
8.1.1.2.2. Nd:YAG Lasers
8.1.1.3. Dual-wavelength near-infrared Lasers
8.2. Middle East & Africa Dermatophytic Onychomycosis Therapeutics Market Outlook, by Indication, Value (US$ Bn), 2019-2032
8.2.1. Key Highlights
8.2.1.1. Distal Subungual Onychomycosis
8.2.1.2. White Superficial Onychomycosis
8.2.1.3. Proximal Subungual Onychomycosis
8.2.1.4. Candidal Onychomycosis
8.2.1.5. Total Dystrophic Onychomycosis
8.3. Middle East & Africa Dermatophytic Onychomycosis Therapeutics Market Outlook, by Gender, Value (US$ Bn), 2019-2032
8.3.1. Key Highlights
8.3.1.1. Male
8.3.1.2. Female
8.4. Middle East & Africa Dermatophytic Onychomycosis Therapeutics Market Outlook, by Age Group, Value (US$ Bn), 2019-2032
8.4.1. Key Highlights
8.4.1.1. 0-18 Years
8.4.1.2. 18-39 Years
8.4.1.3. 40-64 Years
8.4.1.4. 65 Years and Above
8.5. Middle East & Africa Dermatophytic Onychomycosis Therapeutics Market Outlook, by Distribution Channel, Value (US$ Bn), 2019-2032
8.5.1. Key Highlights
8.5.1.1. Institutional Sales
8.5.1.1.1. Hospitals
8.5.1.1.2. Dermatology Clinics
8.5.1.2. Retail Sales
8.5.1.2.1. Retail Pharmacies
8.5.1.2.2. Drug Stores
8.5.1.2.3. Mail Order Pharmacies & Online Sales
8.5.2. BPS Analysis/Market Attractiveness Analysis
8.6. Middle East & Africa Dermatophytic Onychomycosis Therapeutics Market Outlook, by Country, Value (US$ Bn), 2019-2032
8.6.1. Key Highlights
8.6.1.1. GCC Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2019-2032
8.6.1.2. GCC Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2019-2032
8.6.1.3. GCC Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2019-2032
8.6.1.4. GCC Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2019-2032
8.6.1.5. GCC Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019-2032
8.6.1.6. South Africa Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2019-2032
8.6.1.7. South Africa Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2019-2032
8.6.1.8. South Africa Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2019-2032
8.6.1.9. South Africa Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2019-2032
8.6.1.10. South Africa Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019-2032
8.6.1.11. Egypt Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2019-2032
8.6.1.12. Egypt Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2019-2032
8.6.1.13. Egypt Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2019-2032
8.6.1.14. Egypt Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2019-2032
8.6.1.15. Egypt Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019-2032
8.6.1.16. Nigeria Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2019-2032
8.6.1.17. Nigeria Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2019-2032
8.6.1.18. Nigeria Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2019-2032
8.6.1.19. Nigeria Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2019-2032
8.6.1.20. Nigeria Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019-2032
8.6.1.21. Rest of Middle East & Africa Dermatophytic Onychomycosis Therapeutics Market by Treatment, Value (US$ Bn), 2019-2032
8.6.1.22. Rest of Middle East & Africa Dermatophytic Onychomycosis Therapeutics Market by Indication, Value (US$ Bn), 2019-2032
8.6.1.23. Rest of Middle East & Africa Dermatophytic Onychomycosis Therapeutics Market by Gender, Value (US$ Bn), 2019-2032
8.6.1.24. Rest of Middle East & Africa Dermatophytic Onychomycosis Therapeutics Market by Age Group, Value (US$ Bn), 2019-2032
8.6.1.25. Rest of Middle East & Africa Dermatophytic Onychomycosis Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019-2032
8.6.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Product vs Indication Heatmap
9.2. Company Market Share Analysis, 2024
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Bausch Health
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Galderma S.A.
9.4.2.1. Company Overview
9.4.2.2. Product Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. Novartis AG
9.4.3.1. Company Overview
9.4.3.2. Product Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. Pfizer, Inc.
9.4.4.1. Company Overview
9.4.4.2. Product Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. Moberg Pharma AB
9.4.5.1. Company Overview
9.4.5.2. Product Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. Bayer AG
9.4.6.1. Company Overview
9.4.6.2. Product Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Dr. Reddy’s Laboratories Ltd.
9.4.7.1. Company Overview
9.4.7.2. Product Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. Cipla Ltd.
9.4.8.1. Company Overview
9.4.8.2. Product Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. Medimetriks Pharmaceuticals, Inc.
9.4.9.1. Company Overview
9.4.9.2. Product Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. Sanofi S.A.
9.4.10.1. Company Overview
9.4.10.2. Product Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
9.4.11. GlaxoSmithKline Plc.
9.4.11.1. Company Overview
9.4.11.2. Product Portfolio
9.4.11.3. Financial Overview
9.4.11.4. Business Strategies and Development
9.4.12. Teva Pharmaceutical industries Ltd.
9.4.12.1. Company Overview
9.4.12.2. Product Portfolio
9.4.12.3. Financial Overview
9.4.12.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

  • Bausch Health
  • Galderma S.A.
  • Novartis AG
  • Pfizer, Inc.
  • Moberg Pharma AB
  • Bayer AG
  • Dr. Reddy’s Laboratories Ltd.
  • Cipla Ltd.
  • Medimetriks Pharmaceuticals, Inc.
  • Sanofi S.A.
  • GlaxoSmithKline Plc.
  • Teva Pharmaceutical Industries Ltd.
  • Cardinal Health Inc.
  • Viatris Inc.
  • Almirall, S.A
  • Vanda Pharmaceuticals Inc.

Related Topics

Related Reports

Dermatophytic Onychomycosis - Pipeline Insight, 2025 - Product Image

Dermatophytic Onychomycosis - Pipeline Insight, 2025

  • Drug Pipelines
  • 60 Pages
  • Global
From
Dermatophytic Onychomycosis Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Dermatophytic Onychomycosis Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 89 Pages
  • Global
From
Dermatophytic Onychomycosis Treatment - Global Strategic Business Report - Product Image

Dermatophytic Onychomycosis Treatment - Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From
Global Onychomycosis Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global Onychomycosis Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 126 Pages
  • Global
From
Onychomycosis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Onychomycosis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 260 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.